Search
for
Sort by
Research 961–990 of 1000+
- Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Cutaneous microbial biofilm formation as an underlying cause of red scrotum syndrome
- Psoriasiform skin reaction due to Brazilian keratin treatment
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Efficacy, safety, and Pharmacoeconomics of Three Common Strategies for Pediatric Alopecia Areata Patients: A Retrospective Cohort Study
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Plasma proteome–driven identification of druggable immune regulators of alopecia areata, validated by transcriptome and single-cell mapping
- Hypochlorous Acid: Clinical Insights and Experience in Dermatology, Surgery, Dentistry, Ophthalmology, Rhinology, and Other Specialties
- Knowledge, attitudes, and practices toward disease management among alopecia areata patients
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
- The Effectiveness and Safety of Three Treatment Regimens of Topical Minoxidil 5.0%, Betamethasone 0.064% w/w, and Castor and Jojoba Oils for Alopecia Areata: A Multicenter Cohort Study
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Platelet-rich plasma efficacy in alopecia areata patients with normal and elevated levels of antibodies against thyroglobulin and thyroid peroxidase
- Life Style Modification, Does it Make a Difference ??
- COMPARATIVE STUDY BETWEEN INTRALESIONAL INJECTION OF PLATELET RICH PLASMA AND INTRA LESIONAL TRIAMCINOLONE FOR THE TREATMENT OF ALOPECIA AREATA
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Compliance to Topical Minoxidil and Reasons for Discontinuation among Patients with Androgenetic Alopecia
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Bimatoprost in the treatment of eyelash hypotrichosis
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Depositing α-mangostin nanoparticles to sebaceous gland area for acne treatment
- Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata